
July 30, 2015.

July 30, 2015.



July 28, 2015.


The pharma industry has had a year to address MHRA’s April 2014 update to the definition of a critical GCP inspection finding to include trial master files(TMFs) that are “not readily available or accessible”. How has it fared? Rik van Mol reports.





July 23, 2015.

July 22, 2015.

21 July, 2015.



July 21, 2015.


Pharmaceutical Executive
Lisa Henderson discusses how role of social media in post-market adverse event reporting is finally being taken seriously by the FDA.

20 July, 2015.

July 17, 2015.


A quick countdown of this year's Top 50 movers and shakers.

July 15, 2015.

July 15, 2015.

July 14, 2015.